Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell

Kidney International

Volumn 74, Issue 7, 2008, Pages 845-847

  Wools Kaloustian, Kara K ^a   Gupta, Samir K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR;

AFRICA; CHRONIC KIDNEY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EPIDEMIC; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HISTOPATHOLOGY; HIV ASSOCIATED NEPHROPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY PARENCHYMA; MEDICAL PRACTICE; NOTE; PATIENT MONITORING; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; VIREMIA; VIRUS REPLICATION;

EID: 51849112006     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.326     Document Type: Note

References (10)

1. Ross MJ, Klotman PE. HIV-associated nephropathy. AIDS 2004; 18: 1089-1099.
2. Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344: 1979-1984.
3. Kalayjian RC, Franceschini N, Gupta SK et al. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS 2008; 22: 481-487.
4. Schwartz EJ, Szczech LA, Ross MJ et al. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol 2005; 16: 2412-2420.
5. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. The challenge of HIV-1 subtype diversity. N Engl J Med 2008; 358: 1590-1602.
6. Wools-Kaloustian K, Gupta SK, Muloma E et al. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 2007; 22: 2208-2212.
7. Szczech LA, Hoover DR, Feldman JG et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39: 1199-1206.
8. Gonzalez E, Kulkarni H, Bolivar H et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science 2005; 307: 1434-1440.
9. Peters PJ, Moore DM, Mermin J et al. Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008; 74: 925-929.
10. Reid A, Stohr W, Walker S et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46: 1271-1281.